The Valley Desk

NCT03801525 · Interventional trial

Study to Assess the Efficacy and Safety of Ublituximab in Combination With Umbralisib and Venetoclax Compared to Ublituximab in Combination With Umbralisib in Subjects With CLL (ULTRA-V)

Overall registry status Terminated

Phase 2 · Phase 3

Conditions Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov